Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment

10.1186/bcr3495

Saved in:

Bibliographic Details
Main Authors:	Li, J, Czene, K, Brauch, H, Schroth, W, Saladores, P, Li, Y, Humphreys, K, Hall, P
Other Authors:	SURGERY
Format:	Article
Published:	2020
Subjects:	cytochrome P450 2D6 tamoxifen antineoplastic hormone agonists and antagonists adult aged article body mass breast cancer enzyme polymorphism female follow up genetic variability human major clinical study mammographic density mammography quantitative trait treatment response breast tumor congenital malformation genetic polymorphism genetics genotype mammary gland metabolism middle aged pathology prognosis risk factor treatment outcome Aged Antineoplastic Agents, Hormonal Breast Neoplasms Cytochrome P-450 CYP2D6 Female Genotype Humans Mammary Glands, Human Middle Aged Polymorphism, Genetic Prognosis Risk Factors Tamoxifen Treatment Outcome
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/183197
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-183197
record_format	dspace
spelling	sg-nus-scholar.10635-1831972024-04-25T02:36:26Z Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment Li, J Czene, K Brauch, H Schroth, W Saladores, P Li, Y Humphreys, K Hall, P SURGERY cytochrome P450 2D6 tamoxifen antineoplastic hormone agonists and antagonists tamoxifen adult aged article body mass breast cancer enzyme polymorphism female follow up genetic variability human major clinical study mammographic density mammography quantitative trait treatment response breast tumor congenital malformation genetic polymorphism genetics genotype mammary gland mammographic density metabolism middle aged pathology prognosis risk factor treatment outcome Aged Antineoplastic Agents, Hormonal Breast Neoplasms Cytochrome P-450 CYP2D6 Female Genotype Humans Mammary Glands, Human Middle Aged Polymorphism, Genetic Prognosis Risk Factors Tamoxifen Treatment Outcome 10.1186/bcr3495 Breast Cancer Research 15 5 R93 2020-11-10T00:30:15Z 2020-11-10T00:30:15Z 2013 Article Li, J, Czene, K, Brauch, H, Schroth, W, Saladores, P, Li, Y, Humphreys, K, Hall, P (2013). Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment. Breast Cancer Research 15 (5) : R93. ScholarBank@NUS Repository. https://doi.org/10.1186/bcr3495 14655411 https://scholarbank.nus.edu.sg/handle/10635/183197 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	cytochrome P450 2D6 tamoxifen antineoplastic hormone agonists and antagonists tamoxifen adult aged article body mass breast cancer enzyme polymorphism female follow up genetic variability human major clinical study mammographic density mammography quantitative trait treatment response breast tumor congenital malformation genetic polymorphism genetics genotype mammary gland mammographic density metabolism middle aged pathology prognosis risk factor treatment outcome Aged Antineoplastic Agents, Hormonal Breast Neoplasms Cytochrome P-450 CYP2D6 Female Genotype Humans Mammary Glands, Human Middle Aged Polymorphism, Genetic Prognosis Risk Factors Tamoxifen Treatment Outcome
spellingShingle	cytochrome P450 2D6 tamoxifen antineoplastic hormone agonists and antagonists tamoxifen adult aged article body mass breast cancer enzyme polymorphism female follow up genetic variability human major clinical study mammographic density mammography quantitative trait treatment response breast tumor congenital malformation genetic polymorphism genetics genotype mammary gland mammographic density metabolism middle aged pathology prognosis risk factor treatment outcome Aged Antineoplastic Agents, Hormonal Breast Neoplasms Cytochrome P-450 CYP2D6 Female Genotype Humans Mammary Glands, Human Middle Aged Polymorphism, Genetic Prognosis Risk Factors Tamoxifen Treatment Outcome Li, J Czene, K Brauch, H Schroth, W Saladores, P Li, Y Humphreys, K Hall, P Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment
description	10.1186/bcr3495
author2	SURGERY
author_facet	SURGERY Li, J Czene, K Brauch, H Schroth, W Saladores, P Li, Y Humphreys, K Hall, P
format	Article
author	Li, J Czene, K Brauch, H Schroth, W Saladores, P Li, Y Humphreys, K Hall, P
author_sort	Li, J
title	Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment
title_short	Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment
title_full	Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment
title_fullStr	Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment
title_full_unstemmed	Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment
title_sort	association of cyp2d6 metabolizer status with mammographic density change in response to tamoxifen treatment
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/183197
_version_	1800914681327517696

Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment

Similar Items